STRIVE FOR EXCELENCE, BIOMETRIK EXPAND ITS SCOPE OF ACCREDITATION

Writer: Balqist Nadia Rahmah Editor: Oktaviani Utami Dewi

Depok ‚Äď PT Biometrik Riset Indonesia has been serving bioequivalence study for pharmaceutical industry since 2014. To maintain and improve the quality of bioequivalence study services, surveillance and assessments are carried out to expand the scope of the laboratory. The surveillance was held on 28th-29th February, 2024 by National Accreditation and meet all requirements on 25th March, 2024. The newest of scope certificate of accreditation issued on April 23rd, 2024, along with the additional ten molecules.

KAN LAMA.png

KAN BARU.png

Thirty molecules were listed on PT Biometrik Riset Indonesia's scope certificate of accreditation. With this expanded scope, we intend to boost customer trust and enable PT Biometrik Riset Indonesia to keep up its active involvement in the growth of the pharmaceutical industry in Indonesia.


Comments (1)

  • Ipin
    Semoga sukses selaluūüĎŹ
    1 month ago Reply

Leave a comment